ANI Pharmaceuticals | Attività Correnti





Attività Correnti Cambiamento Data
AbbVie USD 29.06B 523M 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 423.84M 41.46M 2025-09
Canopy Growth CAD 445.82M 142.46M 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Omeros USD 69.65M 26.53M 2025-06
Perrigo USD 2.8B 81.8M 2025-12
Sun Pharmaceuticals INR 601.36B 75.42B 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12


ANI Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.